Ogloblina O G, Belova L A, Malakhov V N
Vopr Med Khim. 1987 Jul-Aug;33(4):119-24.
A modification is described of the previously developed procedure for isolation of acid stable proteinase inhibitor (ASI) from urine of patients with nephritis. The modified procedure enabled to increase the yield of the inhibitor and to obtain its highly purified preparations. These preparations possessed a property to inhibit effectively the activity of human granulocyte elastase (ki = 10(4) M-1 min-1). The modified procedure is based on affinity chromatography on chymotrypsin-Sepharose 4B, substitution of dialysis by gel filtration on Sephadex G-25, use of alternative methods for concentration of protein fractions instead of membrane ultrafiltration and chromatography on polyamide for ASI depigmentation. The inhibitor yield amounted up to 75% of the initial activity in urine. The possibilities of the human urine ASI use in medical practice are discussed.
本文描述了一种对先前开发的从肾炎患者尿液中分离酸稳定蛋白酶抑制剂(ASI)方法的改进。改进后的方法能够提高抑制剂的产量并获得其高度纯化的制剂。这些制剂具有有效抑制人粒细胞弹性蛋白酶活性的特性(ki = 10⁴ M⁻¹ min⁻¹)。改进后的方法基于在胰凝乳蛋白酶 - 琼脂糖4B上的亲和色谱法,用Sephadex G - 25凝胶过滤代替透析,使用替代方法浓缩蛋白质组分而不是膜超滤,以及用聚酰胺色谱法对ASI进行脱色。抑制剂产量达到尿液中初始活性的75%。讨论了人尿ASI在医学实践中的应用可能性。